Results 91 to 100 of about 19,554 (254)

Clinically Relevant Metallic Nanoparticles in Tuberculosis Diagnosis and Therapy

open access: yesAdvanced Therapeutics, Volume 8, Issue 4, April 2025.
Tuberculosis (TB) remains a global health challenge, with drug‐resistant strains exacerbating the issue. Metallic nanoparticles (MNPs) show promise in TB diagnosis as sensor probes and in combination therapy with antimycobacterial drugs, requiring further pre‐clinical and clinical research for clinical translation.
Christianah Aarinola Akinnawo   +1 more
wiley   +1 more source

Studio di un nuovo algoritmo diagnostico per l’identificazione dei micobatteri non tubercolari (NTM) [PDF]

open access: yes, 2016
NTM (Non tuberculous mycobacteria) count more than 160 species, widely dispersed in the environment as saprophites, but they can cause severe infections in human.
Ruggeri, Melania
core  

Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000–2012

open access: yesEmerging Infectious Diseases, 2014
We analyzed samples from 13,652 patients who had respiratory cultures positive for mycobacteria in Taiwan during 2000–2012 and found that 56.9% were positive for nontuberculous mycobacteria (NTM).
Jung-Yien Chien   +4 more
doaj   +1 more source

Isolation of non-tuberculous mycobacteria among tuberculosis patients during a five-year period in Croatia [PDF]

open access: yes, 2015
Here we evaluated the frequency and identified the main NTM species isolated among all bacteriologically confirmed tuberculosis (TB) patients in Croatia from 2007 to 2011.
Janković Makek, Mateja   +4 more
core   +1 more source

GATA2 Deficiency With Early‐Onset and Progressive Interstitial Lung Disease

open access: yesRespirology Case Reports, Volume 13, Issue 4, April 2025.
GATA2 deficiency is an autosomal dominant disorder with various manifestations including hematologic disease and inborn errors of immunity. The most common respiratory diseases are recurrent respiratory tract infections, pulmonary alveolar proteinosis, and pulmonary hypertension.
Yuriko Sugiura   +7 more
wiley   +1 more source

Anomalies in T cell function are associated with individuals at risk of mycobacterium abscessus complex infection [PDF]

open access: yes, 2018
The increasing global incidence and prevalence of non-tuberculous mycobacteria (NTM) infection is of growing concern. New evidence of person-to-person transmission of multidrug-resistant NTM adds to the global concern.
Bell, Scott C.   +8 more
core   +5 more sources

First report of occurrence of Mycobacterium tuberculosis and Non-tuberculous mycobacteria in a heterozygous carrier of chronic granulomatous patient

open access: yesInternational Journal of Mycobacteriology, 2015
Tuberculosis (TB) is one of the most common infections world-wide, and in 2012, an estimated 8.6 million people developed TB and 1.3 million died from the disease (including 320,000 deaths among HIV-positive people).
Dina Soroush   +5 more
doaj  

Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998

open access: yesMemorias do Instituto Oswaldo Cruz, 2004
Mycobacterium kansasii is the most common cause of pulmonary nontuberculous mycobacteria infection and classical identification of this pathogen needs a time consuming phenotypic tests.
Erica Chimara   +5 more
doaj   +1 more source

Thiourea‐Based Compounds Effectiveness Against the Growth of Mycobacterium kansasii: Synthesis, Biological Activity, and Computational Analysis

open access: yesChemistrySelect, Volume 10, Issue 16, April 25, 2025.
Fifty thiourea derivatives are synthesized and evaluated against Mycobacterium kansasii. Compounds 2, 47, and 49 demonstrate potent extra‐ and intracellular activity without causing macrophage cytotoxicity, even against the hypervirulent strains. Structure–activity relationships and in silico analyses highlight favorable molecular features and predict ...
Sanderson Dias Calixto   +13 more
wiley   +1 more source

Large-Restriction-Fragment Polymorphism Analysis of Mycobacterium chelonae and Mycobacterium terrae Isolates [PDF]

open access: yes, 2003
Mycobacterium chelonae and Mycobacterium terrae were reported to be frequently present in the environment of the Mycobacterium bovis BCG trial area in south India. Six isolates of M. chelonae and four isolates of M.
Daisy Vanitha, J   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy